Frontline Conversations: Enhancing Compliance with USP Chapter <797> in Small and Rural Hospitals
|
|
Activity Overview
Health systems have worked diligently to ensure that they are in compliance with the revised USP Chapter <797> requirements. This Frontline Conversations session will focus on small and rural facilities with expert faculty. This session follows two live webinars that summarized key revisions to the revised USP Chapter <797>, assessing facility and personnel, best practices for training and monitoring personnel, safety features of technologies and standardization of IV compounding, and how institutions can perform a gap analysis of its facility, personnel, polices, and environmental monitoring.
No formal presentation was planned for this session. Attendees submitted questions for the faculty experts.
More in this Series:
Webinars: Mind the Gaps: Assessing Your Institution’s Compliance with USP Chapter <797>
Elevating Compliance: Navigating USP <797> with Technology and Standardization
Engaging the Experts Podcasts: Compliance with USP Chapter <797> in Small and Rural Hospitals
Frontline Conversations: Frontline Conversations: Targeting Compliance Gaps with USP Chapter <797>
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
Target Audience
This activity was planned to meet the educational needs of pharmacists, pharmacy technicians, and medication safety officers practicing in hospitals and health systems.
At the conclusion of this activity, participants should be able to:
- Perform a gap analysis that includes facility, personnel, policy and procedure development and review, environmental monitoring, and accreditation gaps.
- Identify opportunities to implement technologies and standardization that improve safety of IV compounding in small, medium, and large institutions.
Schedule of Activities
How It Works:
Questions pre-submitted during registration were addressed before live questions.
During the session, questions were submitted via the chat.
Faculty
Patricia C. Kienle, RPh, MPA, BCSCP, FASHP, Activity Chair
Director, Accreditation and Medication Safety
Cardinal Health
Wilkes-Barre, Pennsylvania
Patricia Kienle, RPh, MPA, BCSCP, FASHP is Director of Accreditation and Medication Safety for Cardinal Health. She received her pharmacy degree from Philadelphia College of Pharmacy and Science and a Master in Public Administration degree from Marywood University in Scranton, Pennsylvania. She is author of The Chapter <795> Answer Book, The Chapter <797> Answer Book, and The Chapter <800> Answer Book and co-author of Meeting Accreditation Standards: A Pharmacy Preparation Guide. With over 600 invited presentations and 100 publications, she has special interests in medication safety, compounding sterile preparations, accreditation, and regulatory issues.
Orchid Motahari, PharmD, BCSCP, BCOP
Sterile Compounding Oversight
Martha's Vineyard Hospital
Oak Bluffs, Massachusetts
Orchid Motahari, PharmD, BCSCP, BCOP, is the sterile compounding designated person and clinical oncology pharmacist at Martha’s Vineyard Hospital in Oak Bluffs, MA, where she oversees the sterile compounding operations, provides personnel training and ensures regulatory compliance.
Michael Ganio, PharmD, MS, BCSCP, FASHP
Senior Director, Pharmacy Practice and Quality
ASHP
Bethesda, Maryland
Michael Ganio, PharmD, MS, BCSCP, FASHP joined the staff at ASHP as Director of Pharmacy Practice and Quality in January of 2018. As a member of the Center on Medication Safety and Quality team, his responsibilities span the practice of pharmacy and include drug shortages, pharmaceutical quality, sterile and non-sterile drug compounding practices, hazardous drug handling, and the ASHP Standardize 4 Safety initiative. Dr. Ganio earned his Pharm.D. from the Rutgers University Ernest Mario School of Pharmacy and his Master’s degree in Health-System Pharmacy Administration from The Ohio State University College of Pharmacy. He completed a PGY1 Pharmacy Practice residency at The Ohio State University Wexner Medical Center. Dr. Ganio is a Board Certified Pharmacotherapy Specialist (BCPS) and a Board Certified Sterile Compounding Pharmacist (BCSCP).
Relevant Financial Relationship Disclosures
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. The following persons in control of this activity’s content have relevant financial relationships:
- Patricia C. Kienle: BD – Speaker’s Bureau
All other persons in control of content do not have any relevant financial relationships with an ineligible company. As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity.
Provided by ASHP
Supported by an educational grant from Pfizer Inc.